Mitsubishi Ufj Trust & Banking Corp Axogen, Inc. Transaction History

Mitsubishi Ufj Trust & Banking Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$11.5 - $17.96 $4.03 Million - $6.3 Million	-350,710 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$10.62 - $13.12 $102,801 - $127,001	-9,680 Reduced 2.69%	350,710 $4.08 Million
Q2 2020 Aug 13, 2020	SELL	$7.35 - $10.81 $176,326 - $259,331	-23,990 Reduced 6.24%	360,390 $3.33 Million
Q1 2020 May 13, 2020	BUY	$8.38 - $17.34 $13,072 - $27,050	1,560 Added 0.41%	384,380 $4 Million
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $80,719 - $134,292	-7,220 Reduced 1.85%	382,820 $6.85 Million
Q3 2019 Nov 12, 2019	SELL	$12.09 - $20.46 $46,304 - $78,361	-3,830 Reduced 0.97%	390,040 $4.87 Million
Q1 2019 May 13, 2019	SELL	$14.62 - $22.13 $13,158 - $19,917	-900 Reduced 0.23%	393,870 $8.3 Million
Q4 2018 Feb 12, 2019	BUY	$17.09 - $38.25 $6.75 Million - $15.1 Million	394,770 New	394,770 $8.07 Million

179

36.2M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $776M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.